SmithKline Beecham Continues To Pursue Denavir Switch
• By The Tan Sheet
SmithKline Beecham "will continue to work with the FDA to resolve" issues raised in a "not approvable" letter from the agency for the company's Rx-to-OTC switch application of Denavir. The topical 1% penciclovir cream is indicated for the treatment of cold sores, or herpes labialis, in immunocompetent adults.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
